BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23321535)

  • 1. Uncovering the DNA methylome in chronic lymphocytic leukemia.
    Cahill N; Rosenquist R
    Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
    Kanduri M; Cahill N; Göransson H; Enström C; Ryan F; Isaksson A; Rosenquist R
    Blood; 2010 Jan; 115(2):296-305. PubMed ID: 19897574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
    Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
    Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
    Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
    Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
    Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
    Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.
    Oakes CC; Claus R; Gu L; Assenov Y; Hüllein J; Zucknick M; Bieg M; Brocks D; Bogatyrova O; Schmidt CR; Rassenti L; Kipps TJ; Mertens D; Lichter P; Döhner H; Stilgenbauer S; Byrd JC; Zenz T; Plass C
    Cancer Discov; 2014 Mar; 4(3):348-61. PubMed ID: 24356097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylation patterns in chronic lymphocytic leukemia.
    Seeliger B; Wilop S; Osieka R; Galm O; Jost E
    Leuk Lymphoma; 2009 Mar; 50(3):419-26. PubMed ID: 19347729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
    Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
    Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
    Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
    Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
    PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.